# A genetic study of immunity in depression and interactions with childhood maltreatment

**Authors:** Marisol Herrera-Rivero, Daniel L. McCartney, Heather C. Whalley, Klaus Berger, Andrew M. McIntosh, Bernhard T. Baune

PMC · DOI: 10.1038/s41398-026-03935-5 · Translational Psychiatry · 2026-03-19

## TL;DR

This study explores how genetic factors related to immunity and childhood maltreatment interact to influence depression.

## Contribution

The study identifies specific immune genes and pathways that interact with childhood maltreatment to affect depression risk.

## Key findings

- The GHR gene and a myeloid cell differentiation pathway were associated with depression.
- 56 immune gene-CM interactions were linked to depression after meta-analysis.
- Hematopoietic alterations and macrophage-related functions were highlighted in depression development.

## Abstract

Genetic and environmental factors contribute to depression. Among the latter, early life adversity and immune dysregulation have been consistently linked with depression. Childhood maltreatment (CM) is believed to induce immune dysregulation later in life. However, it is not known how CM might interact with genetic immune factors to contribute to the occurrence of depression. We investigated how genetic variability in 2370 genes from 20 immune pathways associates with a broadly-defined lifetime depression phenotype at gene- and pathway-level, and how this variability interacts with CM. Depression analysis was carried out in 13,309 individuals (1867 cases) from Generation Scotland (GS). CM interaction analysis was carried out in a subset of 749 individuals (99 cases) from GS and an independent sample of 509 individuals (96 cases) from the German BiDirect (BD) Study for which both genetic and CM data was available. Interactions with different types of CM were tested using the subscales of the childhood trauma questionnaire (CTQ). These results were meta-analyzed to obtain general gene-CM interactions. We found association of the GHR gene (false discovery rate –FDR– = 0.03, z = 4.2) and Reactome “RUNX1-regulated transcription of genes involved in myeloid cell differentiation pathway” (FDR = 0.016, beta = 1.2) with depression in GS. After meta-analysis, 56 immune gene-CM interactions were associated with depression (FDR < 0.05) in both GS and BD. These exert functions in hematopoiesis, pathogen recognition and stress responses, among others. Network analysis suggested macrophages as main expressing cell types. Our results underscore the involvement of hematopoietic alterations and immune gene-CM interactions in the development of depression.

## Linked entities

- **Genes:** GHR (growth hormone receptor) [NCBI Gene 2690]
- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Genes:** CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, PRKCB (protein kinase C beta) [NCBI Gene 5579] {aka PKC-beta, PKCB, PKCI(2), PKCbeta, PRKCB1, PRKCB2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon) [NCBI Gene 9641] {aka IKK-E, IKK-i, IKKE, IKKI}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, KIR3DL2 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2) [NCBI Gene 3812] {aka 3DL2, CD158K, KIR-3DL2, NKAT-4, NKAT4, NKAT4B}, RBX1 (ring-box 1) [NCBI Gene 9978] {aka BA554C12.1, RNF75, ROC1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MAPKAPK2 (MAPK activated protein kinase 2) [NCBI Gene 9261] {aka MAPKAP-K2, MK-2, MK2}, GHR (growth hormone receptor) [NCBI Gene 2690] {aka GHBP, GHIP}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], TNIK (TRAF2 and NCK interacting kinase) [NCBI Gene 23043] {aka MAP4K7, MRT54}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}, SERPINH1 (serpin family H member 1) [NCBI Gene 871] {aka AsTP3, CBP1, CBP2, HSP47, OI10, PIG14}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, ASB15 (ankyrin repeat and SOCS box containing 15) [NCBI Gene 142685], KIR3DL1 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1) [NCBI Gene 3811] {aka CD158E1, KIR, KIR3DL1/S1, NKAT-3, NKAT3, NKB1}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, FYN (FYN proto-oncogene, Src family tyrosine kinase) [NCBI Gene 2534] {aka SLK, SYN, p59-FYN}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** mental (MESH:D008607), immune dysfunction (MESH:D007154), coronary (MESH:D003323), psychiatric illness (MESH:D001523), neuroinflammation (MESH:D000090862), EA (MESH:D019966), Trauma (MESH:D014947), arteriosclerosis (MESH:D001161), (unipolar) depression syndromes (MESH:D003866), immune dysregulation (OMIM:614878), GS (MESH:D004829), AD (MESH:D000544), CM (MESH:D063766), SA (MESH:D000082002), inflammation (MESH:D007249), EN (MESH:D058069), BD (MESH:C535438), PA (MESH:D059445), bipolar disorder (MESH:D001714)
- **Chemicals:** GS (-), L-glutamine (MESH:D005973), reactive oxygen species (MESH:D017382), PI (MESH:D010716)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs10440649

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039853/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039853/full.md

---
Source: https://tomesphere.com/paper/PMC13039853